Status of progress of bulk drug parks in Gujarat

1. At a Glance

• Bulk Drug Parks are dedicated industrial clusters offering Common Infrastructure Facilities (CIF) to Active Pharmaceutical Ingredient (API) / Key Starting Material (KSM) manufacturers at subsidised rates [S2][S3].
• Aim: cut import dependence on China for bulk drugs, achieve economies of scale, and lower domestic API manufacturing cost [S1][S3].
• Gujarat hosts one of the three approved parks (with Andhra Pradesh and Himachal Pradesh); examinable as part of GS-III (Indian economy / pharma sector / Atmanirbhar Bharat) [S2][S3].

2. Why in the News

• 24 March 2026 PIB note from Department of Pharmaceuticals updated Parliament/public on construction progress, fund utilisation and Environmental Clearance status of the Gujarat park [S1].

3. Background & Evolution

• 20.03.2020 — Union Cabinet approved the scheme "Promotion of Bulk Drug Parks" with outlay of ₹3,000 crore for 3 parks [S1][S3].
• 2022-23 — Three states (Andhra Pradesh, Gujarat, Himachal Pradesh) received in-principle approval after competitive evaluation [S1][S2].
• February 2024 — Gujarat park received Environmental Clearance [S1].
• Antecedent: 2020 Cabinet-approved PLI scheme for KSM/Drug Intermediates/APIs addressing the same import-dependence concern post COVID-19 [S2].

4. Core Static Facts

• Nodal ministry: Ministry of Chemicals and Fertilizers — Department of Pharmaceuticals [S1].
• Scheme outlay: ₹3,000 crore; ceiling per park ₹1,000 crore [S1][S2].
• Funding pattern: 70% of CIF cost for Gujarat & AP; 90% for hilly state Himachal Pradesh [S2].
• Gujarat park location: Tehsil Jambusar, District Bharuch, on 2,015.02 acres [S2].
• State Implementing Agency (SIA): Gujarat Industrial Development Corporation (GIDC) [S1].
• Total project cost (3 parks): ₹6,306.68 crore; Central assistance up to ₹1,000 crore each [S2].
• Other park sites: Haroli, Una (HP) — 1,402.44 acres; K.P. Puram & Kodhada, Thondagi mandal, East Godavari (AP) — 2,000.45 acres [S2].

5. Multi-Dimensional Analysis

Economic - Reduces API import dependence (≈70% of India's API demand sourced from China pre-2020); strengthens "Pharmacy of the World" positioning [S2][S3]. - Subsidised land + utilities (power, water, ETP, steam, solid waste, warehousing) cut unit-level capex/opex for API manufacturers [S2][S3].

Administrative - Centre funds CIF; states act through SIAs (GIDC in Gujarat). Of ₹600 crore released to GIDC in two ₹300 crore tranches, ₹341.44 crore utilised; ₹206.92 crore of ₹274.20 crore state share also utilised on CIF [S1]. - Civil tenders (roads, drainage, water, effluent collection, racks) awarded and largely completed on site; utility tenders (CETP, Solvent Recovery, TSDF) under execution [S1].

Environmental - API manufacturing is solvent- and effluent-intensive; mandatory CETP, Solvent Recovery and TSDF built into CIF [S1]. - Environmental Clearance under EIA Notification 2006 obtained in Feb 2024 — precondition for civil works [S1].

Strategic / Geopolitical - Part of Atmanirbhar Bharat pharma resilience stack alongside PLI (APIs/KSMs) and PLI 2.0 for pharma, reducing single-source vulnerability [S2].

6. Recent Developments (last 12-18 months)

• Feb 2024: Environmental Clearance for Gujarat park [S1].
• 2024-26: GIDC awarded and largely executed civil CIF tenders; utility (CETP/Solvent Recovery/TSDF) tenders awarded, execution ongoing [S1].
• 24 Mar 2026: PIB status update — ₹341.44 cr of ₹600 cr central grant utilised; ₹206.92 cr of ₹274.20 cr state funds utilised [S1].

7. Prelims Hooks

• Scheme "Promotion of Bulk Drug Parks" approved by Union Cabinet on 20 March 2020 [S1].
• Implementing department: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers (NOT MoHFW) [S1].
• Total scheme outlay: ₹3,000 crore; max ₹1,000 crore per park [S1][S2].
• Approved states (FY 2022-23): Andhra Pradesh, Gujarat, Himachal Pradesh [S1][S2].
• Gujarat site: Jambusar tehsil, Bharuch district; 2,015.02 acres [S2].
• Andhra Pradesh site: K.P. Puram & Kodhada, Thondagi mandal, East Godavari [S2].
• Himachal Pradesh site: Haroli tehsil, Una district [S2].
• Central assistance: 70% of CIF (general states), 90% of CIF (Himachal as hilly state) [S2].
• Gujarat SIA: Gujarat Industrial Development Corporation (GIDC) [S1].
• Gujarat park got Environmental Clearance in February 2024 [S1].
• Total combined project cost: ₹6,306.68 crore [S2].
• Two central tranches of ₹300 crore each released to GIDC; ₹341.44 cr utilised by Mar 2026 [S1].

8. Mains Relevance

• GS-III: Indian Economy — Industrial policy; Infrastructure; Investment models; Achievements of Indians in Science & Tech (Pharma).
• GS-II: Government policies/interventions in health sector.
• Question stems: 1. "Discuss how the Bulk Drug Parks scheme complements the PLI initiative in reducing India's pharmaceutical import dependence." (GS-III) 2. "Critically examine the progress and bottlenecks in implementation of Bulk Drug Parks in India." (GS-III) 3. "Evaluate the federal financing model of the Bulk Drug Parks scheme, with special reference to hilly versus non-hilly states." (GS-II)

9. Related Topics to Study Next

• PLI scheme for KSMs/DIs/APIs (2020) — twin pillar of API self-reliance.
• PLI 2.0 for Pharmaceuticals — finished formulations/biologicals.
• Medical Devices Parks scheme — parallel cluster approach.
• Jan Aushadhi / PMBJP — affordable drug access end of chain.
• National Pharmaceutical Pricing Authority (NPPA) — price regulation link.
• EIA Notification 2006 — environmental clearance regime relevant to such parks.
• Atmanirbhar Bharat Abhiyan — overarching framework.
• India-China trade dependency in APIs — strategic context.

10. Common Errors / Trap Areas

• Confusing Bulk Drug Parks (CIF grant, Dept of Pharmaceuticals) with PLI for APIs (production-linked incentive, same department but distinct).
• Wrong ministry: it is Chemicals & Fertilizers / Dept of Pharmaceuticals, NOT Ministry of Health & Family Welfare.
• District for Gujarat is Bharuch (Jambusar) — not Ahmedabad or Vadodara.
• Funding share for Himachal is 90% (not 70%) because of hilly-state classification.
• Scheme caps assistance at ₹1,000 crore per park — easy to confuse with the ₹3,000 crore total outlay.

11. Sources

• [S1] Status of progress of bulk drug parks in Gujarat — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2244474 — (tier: 1)
• [S2] Centre Grants 'in-Principle' Approval of three Bulk Drug Parks to Himachal Pradesh, Gujarat and Andhra Pradesh — https://www.pib.gov.in/PressReleaseIframePage.aspx?PRID=1856080 — (tier: 1)
• [S3] Bulk Drug Park Scheme — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2224376 — (tier: 1)